Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;35(11):996-1009.
doi: 10.1177/15459683211041317. Epub 2021 Sep 10.

Brain Activity Response to Visual Cues for Gait Impairment in Parkinson's Disease: An EEG Study

Affiliations

Brain Activity Response to Visual Cues for Gait Impairment in Parkinson's Disease: An EEG Study

Samuel Stuart et al. Neurorehabil Neural Repair. 2021 Nov.

Abstract

Background. Gait impairments are common in Parkinson's disease (PD) and increase falls risk. Visual cues can improve gait in PD, particularly freezing of gait (FOG), but mechanisms involved in visual cue response are unknown. This study aimed to examine brain activity in response to visual cues in people with PD who do (PD+FOG) and do not report FOG (PD-FOG) and explore relationships between attention, brain activity and gait. Methods. Mobile EEG measured brain activity during gait in 20 healthy older adults and 43 PD participants (n=22 PD+FOG, n=21 PD-FOG). Participants walked for 2-minutes with and without visual cues (transverse lines to step over). We report power spectral density (PSD) in Delta (1-4 Hz), Theta (4-7 Hz), Alpha (8-12 Hz), Beta (14-24 Hz) and Gamma (30-50 Hz) bands within clusters of similarly brain localized independent component sources. Results. PSDs within the parietal and occipital lobes were altered when walking with visual cues in PD, particularly in PD+FOG. Between group, differences suggested that parietal sources in PD, particularly with PD+FOG, had larger activity compared to healthy older adults when walking. Within group, visual cues altered brain activity in PD, particularly in PD+FOG, within visual processing brain regions. In PD participants, brain activity differences with cues correlated with gait improvements, and in PD+FOG those with worse attention required more visual attentional processing (reduced alpha PSD) in the occipital lobe. Conclusions. Visual cues improve gait and influence brain activity during walking in PD, particularly in PD+FOG. Findings may allow development of more effective therapeutics.

Keywords: Parkinson’s disease; brain activity; electroencephalography; visual cues; walking.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Power Spectral Densities in Brain Cluster Locations in people with PD (PD-FOG and PD+FOG) and healthy controls when walking with and without visual cues [Scalp maps, dipole cluster locations and Log PSDs, Significant (P < .05) differences in PSDs denoted by black bar on x axis].
Figure 2.
Figure 2.
Power spectral density of the left parietal cortex when walking without and with visual cues in people with PD (PD-FOG, PD+FOG) and health controls [significant (P<.05) differences in PSDs denoted by black bar on x axis].

Similar articles

Cited by

References

    1. Muslimović D, Post B, Speelman JD, Schmand B, de Haan RJ, CARPA Study Group . Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008;70(23):2241-2247. - PubMed
    1. Giladi N, Treves TA, Simon ES, et al. Freezing of gait in patients with advanced Parkinson's disease. J Neural Transm. 2001;108(1):53-61. - PubMed
    1. Curtze C, Nutt JG, Carlson‐Kuhta P, Mancini M, Horak FB. Levodopa is a double‐edged sword for balance and gait in people with Parkinson's disease. Mov Disord. 2015;30(10):1361-1370. - PMC - PubMed
    1. Pelicioni PHS, Brodie MA, Latt MD, et al. Head and trunk stability during gait before and after levodopa intake in Parkinson's disease subtypes. Exp Gerontol. 2018;111:78-85. - PubMed
    1. Henderson EJ, Lord SR, Brodie MA, et al. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15(3):249-258. - PubMed

Publication types